CIK 0001862150
- Emerging growth company
Cingulate Inc.
Sign in to watch- Ticker
- CING
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 863825535
- Phone
- +1 913-942-2300
- Business address
- 1901 W. 47TH PLACE, KANSAS CITY, KS, 66205
- Former names
- Cingulate Inc.
Securities
- CING Common Stock Nasdaq
- CINGW Warrants Nasdaq
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Executive Officer bought 10,000 shares at $1.02 ($10,166)
- 4 Open-market buy Director bought 28,934 shares at $0.98 ($28,422)
- 4 Open-market buy Chief Executive Officer bought 15,000 shares at $1.01 ($15,150)
- 4 Open-market buy Corporate Controller bought 7,548 shares at $0.99 ($7,468)
- 4 Open-market buy EVP and COO bought 1,111 shares at $0.90 ($1,000)
- 4 Open-market buy Corporate Controller bought 5,017 shares at an average $0.98 ($4,916)
- 4 Open-market buy EVP, GC and Secretary bought 3,575 shares at $0.84 ($3,003)
- 4 Open-market buy Director bought 85,000 shares at $0.88 ($74,851)
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 17,532 shares at $1.27 ($22,208)
- 4 Open-market buy Corporate Controller bought 3,500 shares at $1.50 ($5,250)
- 4 Open-market buy Director bought 74,500 shares at $1.52 ($113,225)
- 4 Open-market buy EVP and COO bought 636 shares at $1.57 ($999)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Open-market buy EVP and COO bought 200 shares at $1.18 ($236)
Page 6 of 9 · 175 filings